Die Bedeutung der Proteinkinase A und der Ca2+/Calmodulin abhängigen Proteinkinase II für das Sarkoplasmatische Retikulum Kalziumleck in der humanen Hypertrophie und Herzinsuffizienz

Herting, Jonas

dc.contributor.advisor	Sossalla, Samuel T. Prof. Dr.
dc.contributor.author	Herting, Jonas
dc.date.accessioned	2022-09-22T09:24:45Z
dc.date.available	2022-09-29T00:50:14Z
dc.date.issued	2022-09-22
dc.identifier.uri	http://resolver.sub.uni-goettingen.de/purl?ediss-11858/14251
dc.identifier.uri	http://dx.doi.org/10.53846/goediss-9451
dc.language.iso	deu	de
dc.rights	Attribution-NonCommercial 4.0 International	*
dc.rights.uri	http://creativecommons.org/licenses/by-nc/4.0/	*
dc.subject.ddc	610	de
dc.title	Die Bedeutung der Proteinkinase A und der Ca2+/Calmodulin abhängigen Proteinkinase II für das Sarkoplasmatische Retikulum Kalziumleck in der humanen Hypertrophie und Herzinsuffizienz	de
dc.type	doctoralThesis	de
dc.contributor.referee	Sossalla, Samuel T. Prof. Dr.
dc.date.examination	2022-09-22	de
dc.description.abstracteng	Sarcoplasmic reticulum (SR) Ca2+ leak through ryanodine receptor type 2 (RyR2) hyperphosphorylation is a key pathomechanism in human heart failure (HF). The resulting increased spontaneous diastolic calcium release promotes arrhythmic events and compromises cardiac contractility. Protein kinase A (PKA) and Ca2+/calmodulin-dependent protein kinase II (CaMKII) have been identified as potential mediators of RyR2 dysregulation, but their respective contribution to the development of HF has been controversially discussed. Sossalla et al. (Circulation 2010) demonstrated that inhibition of CaMKII in human HF reduces SR Ca2+ leak and improves contractility. The present work is the first to comprehensively investigate the role of both kinases in the transition from human afterload-induced hypertrophy to HF. Analyses of RyR2 expression and phosphorylation demonstrated increased RyR2 expression in compensated afterload-induced hypertrophy compared to healthy donor hearts. Relative RyR2 phosphorylation was not significantly altered at the specific phosphorylation sites of either PKA or CaMKII. In HF, however, there was a pronounced CaMKII-dependent hyperphosphorylation of RyR2 at an unchanged RyR2 expression, whereas PKA-dependent regulation was not detectable. This finding was independent from previous β-blocker treatment. In addition, Ca2+ cycling was investigated by epifluorescence and confocal laser scanning microscopy in isolated cardiomyocytes from both pathologies. In HF, the SR Ca2+ leak was nearly doubled in comparison to compensated cardiac hypertrophy. This was associated with a significant reduction of systolic Ca2+ release and SR Ca2+ load. Accordingly, in cardiac hypertrophy inhibitors of both kinases reduced the SR Ca2+ leak. In HF, CaMKII inhibition but not inhibition of PKA yielded a reduction of the SR Ca2+ leak. Moreover, PKA inhibition further reduced SR Ca2+ load and systolic Ca2+ transients. In conclusion, these results show that in compensated hypertrophy both CaMKII and PKA functionally regulate RyR2 and may induce SR Ca2+ leak. In the transition from hypertrophy to HF, the diastolic Ca2+ leak increases and disturbed Ca2+ cycling occurs. This is associated with an increase in CaMKII- but not PKA-dependent RyR2 phosphorylation. Inhibition of CaMKII may thus represent a promising therapeutic approach for the treatment of arrhythmias and contractile dysfunction in human HF.	de
dc.contributor.coReferee	Katschinski, Dörthe Prof. Dr.
dc.subject.eng	heart failure	de
dc.subject.eng	protein kinase A	de
dc.subject.eng	CaMKII	de
dc.subject.eng	calcium cycling	de
dc.subject.eng	hypertrophy	de
dc.identifier.urn	urn:nbn:de:gbv:7-ediss-14251-1
dc.affiliation.institute	Medizinische Fakultät	de
dc.subject.gokfull	Medizin (PPN619874732)	de
dc.subject.gokfull	Physiologie / Pathophysiologie - Allgemein- und Gesamtdarstellungen (PPN619875283)	de
dc.subject.gokfull	Innere Medizin - Allgemein- und Gesamtdarstellungen (PPN619875747)	de
dc.description.embargoed	2022-09-29	de
dc.identifier.ppn	1817360701
dc.identifier.orcid	0000-0002-3854-1078	de
dc.notes.confirmationsent	Confirmation sent 2022-09-22T09:45:01	de

Dateien

Name:Herting_Jonas_Dissertation - SUB.pdf

Größe:2.375Mb

Format:PDF

Öffnen

Name:: Herting_Jonas_Dissertation - ...
Größe:: 2.375Mb
Format:: PDF

Öffnen

Das Dokument erscheint in:

Human- und Zahnmedizin [2871]

Zur Kurzanzeige